NASDAQ: LQDA · Health Care / Biotechnology: Pharmaceutical Preparations

Liquidia Corporation

How Liquidia Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$4.0B

Price

$44.99

P/E

28.9

EPS (TTM)

$1.56

1-year return

100.4%

Dividend yield

0.0%

52-week range

$26.68–$44.99

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources